**Core Concept**
Selective Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) are a class of antidepressant medications that work by inhibiting the reuptake of both serotonin and norepinephrine neurotransmitters in the synaptic cleft, thereby increasing their concentration and activity in the brain. This mechanism is crucial for their therapeutic effects in treating depression, anxiety disorders, and other conditions.

**Why the Correct Answer is Right**
SNRIs, such as venlafaxine and duloxetine, act by inhibiting the serotonin transporter (SERT) and norepinephrine transporter (NET) proteins, which are responsible for the reuptake of serotonin and norepinephrine, respectively. By blocking these transporters, SNRIs increase the availability of these neurotransmitters for binding to their respective receptors, leading to enhanced neurotransmission and improved mood regulation. The dual mechanism of action of SNRIs makes them effective in treating a range of conditions, including major depressive disorder, generalized anxiety disorder, and fibromyalgia.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is likely to be incorrect, as it does not accurately describe the mechanism of action of SNRIs.
**Option B:** SNRIs do not primarily work by increasing the production of serotonin and norepinephrine, but rather by blocking their reuptake.
**Option C:** While SNRIs can have effects on other neurotransmitter systems, their primary mechanism of action is the inhibition of serotonin and norepinephrine reuptake.

**Clinical Pearl / High-Yield Fact**
It's essential to remember that SNRIs can have a higher risk of serotonin syndrome, a potentially life-threatening condition, when used in combination with other serotonergic medications or in patients with certain medical conditions.

**Correct Answer:** D.